Authors
Loading...
Recent findings show anti-resorptive treatment increases atypical femur fracture risk, indicating new management strategies.
Collins et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: